Use of a Virtual Reality Cognitive Stimulation Programme for Breast Cancer Patients Wishing to Restart or Maintain a Professional Activity
Cog-RV
1 other identifier
interventional
23
1 country
1
Brief Summary
The study concerns patients who have been treated for breast cancer, have cognitive problems and are planning to return to work or are currently working and wish to begin cognitive rehabilitation. Patients will follow the Virtual Reality program developed for the study, during the cognitive rehabilitation usually proposed in the establishment, at the rate of a weekly session of 10-15 minute for 6 weeks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable breast-cancer
Started May 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 9, 2024
CompletedFirst Posted
Study publicly available on registry
February 20, 2024
CompletedStudy Start
First participant enrolled
May 23, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 6, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 6, 2026
CompletedFebruary 10, 2026
February 1, 2026
1.7 years
February 9, 2024
February 6, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Proportion of patients adhering to the Virtual Reality program
Adherence is defined as the completion of at least 5 of the 6 sessions planned.
At 6 weeks
Study Arms (1)
Virtual Reality sessions
EXPERIMENTALInterventions
One session during 10-15 minutes per week for 6 weeks.
Eligibility Criteria
You may qualify if:
- Patients \>18 years of age
- Patient with breast cancer for whom adjuvant chemotherapy has been administered; maintenance treatments (e.g. Trastuzumab, hormone therapy) are eligible,
- Maximum 2 years after completion of adjuvant treatment,
- Patients planning to return to work or who have returned to work in the past year,
- Signature of informed consent prior to any specific procedure relating to the study,
- Patient affiliated to a social security system.
You may not qualify if:
- Patients suffering from illnesses or conditions that impair their ability to understand, follow and/or comply with study procedures,
- Patients with personality disorders and/or psychiatric pathology,
- Patients deprived of their liberty or placed under the authority of a guardian,
- Pregnant women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre François Baclesse
Caen, France
Related Publications (1)
Vieira Jales I, Hummel E, Clarisse B, Gouranton V, Cogne M, Lecuyer A, Leconte A, Lequesne J, Ahmed-Lecheheb D, Morel A, Fernette M, Joly F, Lange M. Virtual reality-based cognitive rehabilitation programme to support employment in patients with breast cancer: protocol for the Cog-RV pilot study. BMJ Open. 2025 Dec 15;15(12):e112196. doi: 10.1136/bmjopen-2025-112196.
PMID: 41401994DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 9, 2024
First Posted
February 20, 2024
Study Start
May 23, 2024
Primary Completion
February 6, 2026
Study Completion
February 6, 2026
Last Updated
February 10, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share